Immunolight Selected to Present at 2024 Future in Review Conference
Immunolight is excited to announce that we have been selected as one of twelve start-up companies featured at the 2024 Future in Review Conference (FiRe) in Palos Verdes, California.
This prestigious recognition highlights our groundbreaking contributions to the field of medicine, particularly our revolutionary advancements with Immunolight Cancer Therapy (ICT), our experimental, non-chemotherapy cancer treatment for solid tumors. This novel, innovative technology has the potential to transform the landscape of cancer treatment, offering new hope and improved outcomes for patients worldwide. We are also excited to share how our technology can innovate commercial and industrial uses of adhesives, solar and the generation of color.
The Future in Review Conference is renowned for bringing together the most forward-thinking leaders in science and technology. As a featured presenter, Immunolight will have the opportunity to showcase our latest advancements and engage with top experts and thought leaders in various industries. We’re eager to share our progress, exchange ideas, and explore potential collaborations across the medical and commercial landscape.
“For years the Future in Review Conference has showcased events and trends that will dramatically impact the world as we know it today,” said Immunolight President Harold Walder. “We are honored to be selected to participate with this elite group and excited to showcase what we hope will be a paradigm shift in the treatment of cancer.”
The 2024 Future in Review Conference will take place from October 20-23 at the Terranea Resort in Palos Verdes, California.